IL315832A - Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders - Google Patents
Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersInfo
- Publication number
- IL315832A IL315832A IL315832A IL31583224A IL315832A IL 315832 A IL315832 A IL 315832A IL 315832 A IL315832 A IL 315832A IL 31583224 A IL31583224 A IL 31583224A IL 315832 A IL315832 A IL 315832A
- Authority
- IL
- Israel
- Prior art keywords
- psychoactive
- medicines
- disorders
- neurological conditions
- treating psychiatric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263325757P | 2022-03-31 | 2022-03-31 | |
| US202263328343P | 2022-04-07 | 2022-04-07 | |
| PCT/US2022/074369 WO2023015154A1 (en) | 2021-08-06 | 2022-08-01 | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders |
| US202363437000P | 2023-01-04 | 2023-01-04 | |
| PCT/US2023/012196 WO2023191952A1 (en) | 2022-03-31 | 2023-02-02 | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL315832A true IL315832A (en) | 2024-11-01 |
Family
ID=88203364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL315832A IL315832A (en) | 2022-03-31 | 2023-02-02 | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4499066A1 (en) |
| JP (1) | JP2025510790A (en) |
| KR (1) | KR20240165982A (en) |
| CN (1) | CN119095593A (en) |
| AU (1) | AU2023241546A1 (en) |
| CA (1) | CA3254727A1 (en) |
| IL (1) | IL315832A (en) |
| MX (1) | MX2024012095A (en) |
| TW (1) | TW202345789A (en) |
| WO (1) | WO2023191952A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025535312A (en) * | 2022-10-20 | 2025-10-24 | トランセンド セラピューティクス，インコーポレイテッド | Preparation of phenethylamines and cathinones and their stereoisomers and their precursors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996039133A1 (en) * | 1995-06-06 | 1996-12-12 | Neurobiological Technologies, Inc. | Novel n-substituted-2-amino-3',4'-methylene-dioxypropiophenones |
| US8575194B1 (en) * | 2004-08-31 | 2013-11-05 | Jack William Schultz | Treatment methods of cognitive, emotional and mental ailments and disorders |
| EP2931291B1 (en) * | 2012-12-11 | 2021-10-20 | The McLean Hospital Corporation | Xenon treatment as an adjunct to psychotherapy for psychiatric disorders |
| WO2017151980A1 (en) * | 2016-03-03 | 2017-09-08 | Segreti Louis M | Cannabis-based bioactive formulations and methods for use thereof |
| US20230218570A1 (en) * | 2020-06-17 | 2023-07-13 | Lobe Sciences Ltd. | Methods and Compositions for Treating Mild Traumatic Brain Injury, Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress Disorder |
| EP4380588A4 (en) * | 2021-08-06 | 2025-10-08 | Transcend Therapeutics Inc | Psychoactive drugs and their use in the treatment of psychiatric and neurological diseases and disorders |
| WO2023081403A1 (en) * | 2021-11-05 | 2023-05-11 | Terran Biosciences Inc. | Isotopologes, salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof |
-
2023
- 2023-02-02 CN CN202380031652.9A patent/CN119095593A/en active Pending
- 2023-02-02 EP EP23781540.2A patent/EP4499066A1/en active Pending
- 2023-02-02 IL IL315832A patent/IL315832A/en unknown
- 2023-02-02 KR KR1020247034657A patent/KR20240165982A/en active Pending
- 2023-02-02 CA CA3254727A patent/CA3254727A1/en active Pending
- 2023-02-02 WO PCT/US2023/012196 patent/WO2023191952A1/en not_active Ceased
- 2023-02-02 JP JP2024556474A patent/JP2025510790A/en active Pending
- 2023-02-02 AU AU2023241546A patent/AU2023241546A1/en active Pending
- 2023-02-06 TW TW112104131A patent/TW202345789A/en unknown
-
2024
- 2024-09-30 MX MX2024012095A patent/MX2024012095A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2024012095A (en) | 2025-01-09 |
| JP2025510790A (en) | 2025-04-15 |
| CA3254727A1 (en) | 2023-10-05 |
| EP4499066A1 (en) | 2025-02-05 |
| KR20240165982A (en) | 2024-11-25 |
| WO2023191952A1 (en) | 2023-10-05 |
| AU2023241546A1 (en) | 2024-10-17 |
| CN119095593A (en) | 2024-12-06 |
| TW202345789A (en) | 2023-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202212876B (en) | 4-oxo-3,4-dihydroquinazolinon compounds for the treatment of braf-associated diseases and disorders | |
| GB201911024D0 (en) | Compounds for use in a method of treating or preventing neurological and/or psychiatric disorders | |
| IL285649A (en) | Azepino-indoles and other heterocycles for treating brain disorders | |
| IL310334A (en) | Psychoactive drugs and their use to treat psychiatric and neurological conditions and disorders | |
| ES3051032T3 (en) | Modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders | |
| IL315832A (en) | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders | |
| IL307607A (en) | Tetracyclic compounds for treating brain disorders | |
| MX2022011518A (en) | Methods of treating proteinopathy- associated wandering. | |
| GB202004498D0 (en) | Activity-dependent gene therapy for neurological disorders | |
| CA208375S (en) | Mouth tape for treating sleep disorders | |
| GB201914034D0 (en) | Treatment of neurological disorders | |
| IL321201A (en) | Methods of treating neurological disorders | |
| IL313539A (en) | Methods for treating neurological disorders | |
| HK40120411A (en) | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders | |
| HK40112015A (en) | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders | |
| HK40120964A (en) | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders | |
| IL316269A (en) | Pyridine derivatives for treating psychiatric disorders | |
| HK40112016A (en) | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders | |
| IL311854A (en) | Compositions and methods for treating neurological disorders with combination products | |
| IL311852A (en) | Compositions and methods for treating neurological disorders | |
| PL4135840T3 (en) | Water-soluble, modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders | |
| IL319150A (en) | Heteroaromatic compounds for the treatment of neurological disorders | |
| EP4229035A4 (en) | Intranasal administration of suramin for treating nervous system disorders | |
| CA208376S (en) | Mouth tape for treating sleep disorders | |
| CA3286002A1 (en) | Antisense oligonucleotides for the treatment of neurological disorders |